Because many authors do not have funding for Open Access, the IJTLD is a hybrid journal (i.e., a subscription-based journal that offers an OA option for authors with funds available).
A subscription provides immediate access to Editorials, Original Articles, State of the Art Reviews, Letters and Correspondence on clinical and biological aspects of lung disease and lung health,
Individuals and Institutes can subscribe to the IJTLD online or in print (see link below for details).
Union members can get support with access – please contact Union Membership.
We have recently launched the IJTLD Clinical Standards in Lung Health for optimal management of patients.
Thanks to the support of the Oskar-Helene-Heim Foundation and the Günther Labes Foundation, the first four Clinical Standards will be Open Access and freely available to our global audience of clinicians for patient care. There will also be an Introduction to the IJTLD Clinical Standards on PTLD and LTBI at the 52nd Union World Conference on Lung Health on Wednesday 20th October from 16:00–17:00 (CET).
The first of the series, Clinical Standards for the assessment, management and rehabilitation of post-TB lung disease has been published in the October issue of IJTLD and is free to read here with an accompanying free Editorial.
The latest peer-reviewed articles on TB and HIV; respiratory diseases such as asthma and COPD; and the hazards of tobacco and air pollution. Recent coverage has expended to include COVID-19 and the interplay between TB-COVID-19 and other co-morbidities.
Advertising or sponsoring content is an effective means of reaching clinicians, researchers, health workers, decision makers and students.
Sponsors can support the creation of a Collection or a Supplement on a relevant topic of interest, either in print or a digital collection of articles, for elevated visibility of your products and services.
Other opportunities include being involved in the creation of informative Posters, Infographics, or scientific Animations to clarify relevant biological processes.
The IJTLD welcomes submissions on COVID-19 and we fast-track articles on topical issues, including the potential impact on TB services and articles that improve our understanding of the role that other risk factors – including diabetes, obesity, smoking, air quality, asthma and COPD – have on the impact of COVID-19.
IJTLD Fast-Track Articles
In order to share scientific research of immediate concern as rapidly as possible, The Union is fast-tracking the publication of certain accepted articles from the IJTLD and publishing them in full on our website, prior to their publication in the Journal. Read fast-track articles:
On 18th July 2021, we celebrate the 100th anniversary of the first use of the BCG vaccine for TB. An Editorial in IJTLD discusses BCG’s efficacy, heterologous protection and controversial link with COVID-19. The preprint is free to read.
An Editorial for IJTLD highlights the importance of TB preventive treatment (TPT) and the launch by WHO, governments, civil society and other partners of a ‘Call to Action’ for broader access to TPT for those in need. The article is free to read.
In this Correspondence accepted article for IJTLD, the authors found a 67.4% decrease in testing, a 66.9% decrease in bacteriologically confirmed (bac+) diagnosis and a 58.9% decrease in diagnosis of all forms TB. The preprint is free to read.